Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This randomised trial aims to assess the role of sildenafil in improving oxygenation amongst hospitalised patients with COVID19.
Description: Mean difference in alveolar oxygen pressure to inspired oxygen fraction (Pa/Fi) ratios.
Measure: Arterial Oxygenation Time: One hour after sildenafil administrationDescription: Mean difference in alveolar oxygen pressure to inspired oxygen fraction (Pa/Fi) ratios.
Measure: Arterial Oxygenation Time: Daily until the end of follow-up (up to 15 days after randomisation)Description: Mean difference in the alveolo-arterial gradient between study groups.
Measure: Alveolo-arterial gradient Time: One hour after sildenafil administrationDescription: Mean difference in the alveolo-arterial gradient between study groups.
Measure: Alveolo-arterial gradient Time: Daily until the end of follow-up (up to 15 days after randomisation)Description: Proportion of patients requiring admission to an intensive care unit in each study group
Measure: Intensive care unit admission Time: Up to two weeks after randomisationDescription: Proportion of patients requiring noninvasive mechanical ventilation o high-flow nasal cannula unit in each study group
Measure: Noninvasive Mechanical Ventilation or Requirement of High-Flow Nasal Cannula Time: Up to two weeks after randomisationDescription: Proportion of patients requiring invasive mechanical ventilation in each study group
Measure: Invasive mechanical ventilation Time: Up to two weeks after randomisationDescription: Proportion of patients that survived COVID19 in each study group
Measure: Survival Time: Up to two weeks after randomisationDescription: Adverse events attributable to sildenafil use.
Measure: Adverse events Time: Up to two weeks after randomisationAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports